WithdrawnNot Applicable

Phototherapy For Treatment Of Raynaud's Phenomenon

Stopped: no funding or staff

United States0Started 2022-08

Plain-language summary

To determine if blue light therapy can improve the symptoms of Raynaud's phenomenon, and provide parameters for ultimately designing commercial treatment devices, an investigational stationary phototherapy unit was designed and built.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Must have a current diagnosis by a physician of Raynaud's Phenomenon/Syndrome Exclusion Criteria: * Those with active ischemic digital ulcers or gangrene as the cold exposure can be a safety hazard for them. * Inability of the subject to place their hands into the PTD portal because of physical size or discomfort. * Inability of the subject to wear protective eyewear. * Anyone, who in the judgement of any of the investigators, would be unable to safely complete the study procedures. * Females who are pregnant. * Adults unable to consent for any reason not explicitly stated herein.

What they're measuring

Change in Visual Analog Scale (VAS) of Pain

Timeframe: 4 hours

Change in Visual Analog Scale (VAS) of Numbness

Timeframe: 4 hours

Trial details

NCT IDNCT04898036

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03

View on ClinicalTrials.gov More Raynaud Disease trials